ArticleOpen forum infectious diseases2026

Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017-2019.

Adam Abdullahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.